Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV.

Aged Anti-HIV Agents / adverse effects Cardiovascular Diseases / diagnosis Female HIV Infections / diagnosis HIV Long-Term Survivors Health Status Humans Longitudinal Studies Male Middle Aged Preventive Health Services Prospective Studies Protective Factors Risk Assessment Risk Factors Risk Reduction Behavior Smokers Smoking / adverse effects Smoking Cessation Smoking Cessation Agents / administration & dosage Time Factors Treatment Outcome United States / epidemiology Veterans Health Viral Load
HIV Smoking Smoking cessation Smoking cessation pharmacotherapy Veterans

Journal

Progress in cardiovascular diseases
ISSN: 1873-1740
Titre abrégé: Prog Cardiovasc Dis
Pays: United States
ID NLM: 0376442

Informations de publication

Date de publication:
Historique:
received: 19 01 2020
accepted: 19 01 2020
pubmed: 29 1 2020
medline: 23 6 2020
entrez: 29 1 2020
Statut: ppublish

Résumé

Smoking is highly prevalent among people living with HIV (PLWH) and increases cardiovascular risk. Pharmacotherapies such as nicotine replacement therapy (NRT), bupropion, and varenicline help to reduce smoking, though rates of receipt among PLWH compared with HIV-uninfected persons are unknown. Among 814 PLWH and 908 uninfected patients enrolled in the Veterans Aging Cohort Study (2012-2017) who reported current smoking, we used marginal multivariable log-linear regression models to estimate adjusted relative risks (ARR) of receiving pharmacotherapy by HIV status. We also assessed patient-level factors associated with pharmacotherapy receipt within each group. In multivariable analyses, receipt of NRT was less likely among PLWH relative to uninfected participants (ARR 0.77, 95% CI 0.67, 0.89). In both populations, documented mental health disorders and contemplation to quit were associated with greater likelihood of receiving pharmacotherapy. Further research is needed to explore potential treatment disparities.

Identifiants

DOI: 10.1016/j.pcad.2020.01.003 PMID: 31987807 PMC: PMC7251937
pubmed: 31987807
pii: S0033-0620(20)30013-X
doi: 10.1016/j.pcad.2020.01.003
pmc: PMC7251937
mid: NIHMS1571394
pii:
doi:

Substances chimiques

Anti-HIV Agents 0
Smoking Cessation Agents 0

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-124

Subventions

Organisme : NCI NIH HHS
ID : R01 CA243907
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020795
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA026224
Pays : United States
Organisme : NIAAA NIH HHS
ID : U10 AA013566
Pays : United States
Organisme : HSRD VA
ID : IK2 HX002398
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL142103
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020790
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA020799
Pays : United States
Organisme : NIDA NIH HHS
ID : K23 DA045957
Pays : United States
Organisme : NIAAA NIH HHS
ID : U24 AA020794
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Nicotine Tob Res. 2013 Aug;15(8):1436-45
pubmed: 23430708
Am J Epidemiol. 2004 Aug 15;160(4):301-5
pubmed: 15286014
J Am Coll Cardiol. 2018 Aug 28;72(9):1030-1045
pubmed: 30139432
Subst Abus. 2016 Apr-Jun;37(2):315-22
pubmed: 26167725
Crit Care Med. 2013 Jun;41(6):1458-67
pubmed: 23507717
Am J Epidemiol. 2004 Apr 1;159(7):702-6
pubmed: 15033648
AIDS Educ Prev. 2009 Jun;21(3 Suppl):54-64
pubmed: 19537954
Antivir Ther. 2008;13(3):389-97
pubmed: 18572752
Addiction. 2002 May;97(5):517-31
pubmed: 12033653
Drug Alcohol Depend. 2017 May 1;174:113-120
pubmed: 28324813
Z Gesamte Hyg. 1978 Oct;24(10):793-800
pubmed: 735215
Lancet. 2003 Jul 5;362(9377):22-9
pubmed: 12853195
J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):226-30
pubmed: 24226058
PLoS One. 2014 Mar 25;9(3):e92606
pubmed: 24667813
Enferm Infecc Microbiol Clin. 2006 Oct;24(8):509-11
pubmed: 16987469
Alcohol Clin Exp Res. 2007 Jul;31(7):1208-17
pubmed: 17451397
Nicotine Tob Res. 2005 Aug;7(4):511-22
pubmed: 16085522
Ann Med. 2012 Sep;44(6):588-97
pubmed: 22860882
AIDS. 2019 Apr 1;33(5):903-912
pubmed: 30649058
AIDS Behav. 2012 Feb;16(2):288-94
pubmed: 21301950
Am J Health Behav. 2012 Jan;36(1):75-85
pubmed: 22251785
Patient Prefer Adherence. 2010 Oct 05;4:355-62
pubmed: 21049087
JAMA Intern Med. 2013 Apr 22;173(8):614-22
pubmed: 23459863
Curr HIV/AIDS Rep. 2013 Sep;10(3):199-206
pubmed: 23793823
Am J Public Health. 2010 Oct;100(10):1896-903
pubmed: 20724677
Nicotine Tob Res. 2008 Dec;10(12):1691-715
pubmed: 19023823
AIDS Behav. 2010 Aug;14(4):824-35
pubmed: 18777131
Cochrane Database Syst Rev. 2013 May 31;(5):CD009329
pubmed: 23728690
AIDS Patient Care STDS. 2012 Jan;26(1):12-9
pubmed: 22007690
Nicotine Tob Res. 2004 Feb;6(1):71-7
pubmed: 14982690
Med Care. 1985 Dec;23(12):1358-71
pubmed: 3910973
J Gen Intern Med. 2007 Jun;22(6):749-54
pubmed: 17503106
Addiction. 2013 Aug;108(8):1497-502
pubmed: 23668486
Am Heart J. 2006 Jun;151(6):1147-55
pubmed: 16781213
Issues Ment Health Nurs. 2012 Oct;33(10):665-9
pubmed: 23017042
Med Care. 2006 Aug;44(8 Suppl 2):S13-24
pubmed: 16849964
Addict Behav. 2004 Aug;29(6):1067-83
pubmed: 15236808
J Gen Intern Med. 1999 May;14(5):274-80
pubmed: 10337036
Nurs Adm Q. 2015 Oct-Dec;39(4):311-8
pubmed: 26340242
AIDS Patient Care STDS. 2002 Jan;16(1):39-42
pubmed: 11839217
Med Care. 2006 Aug;44(8 Suppl 2):S25-30
pubmed: 16849965
Med Care. 2012 Feb;50(2):179-87
pubmed: 20881876
AIDS Behav. 2009 Jun;13(3):545-54
pubmed: 18066659
Lancet. 2016 Jun 18;387(10037):2507-20
pubmed: 27116918
HIV Med. 2011 Aug;12(7):412-21
pubmed: 21251183
J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):149-63
pubmed: 23187941
N Engl J Med. 2005 Feb 10;352(6):596-607
pubmed: 15703424
Behav Med. 2011 Jul;37(3):77-80
pubmed: 21895424
Med Care. 1998 Jul;36(7):1085-97
pubmed: 9674625
Nicotine Tob Res. 2013 Jan;15(1):247-54
pubmed: 22589421
Lancet HIV. 2018 Mar;5(3):e126-e135
pubmed: 29329763
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Addict Behav. 2011 Jan-Feb;36(1-2):61-7
pubmed: 20875704
J Acquir Immune Defic Syndr. 2014 Dec 1;67(4):397-404
pubmed: 25202921
Clin Infect Dis. 2000 Sep;31(3):808-12
pubmed: 11017836
Mayo Clin Proc. 2013 Mar;88(3):226-33
pubmed: 23489449

Auteurs

Shahida Shahrir (S)

Department of Health Services, University of Washington School of Public Health, Seattle, WA, USA. Electronic address: sshahrir@medicine.washington.edu.

Kristina Crothers (K)

Pulmonary and Critical Care Section, VA Puget Sound Health Care System, Seattle, WA, USA.

Kathleen A McGinnis (KA)

Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA.

Kwun C G Chan (KCG)

Departments of Biostatistics and Health Services, University of Washington School of Public Health, Seattle, WA, USA.

Jared M Baeten (JM)

Departments of Global Health, Medicine and Epidemiology, University of Washington School of Public Health, Seattle, WA, USA.

Sarah M Wilson (SM)

Durham Veterans Affairs Healthcare System, Durham, NC, USA.

Adeel A Butt (AA)

VA Pittsburgh Healthcare System, Pittsburgh, PA, USA; Weill Cornell Medical College, New York, NY, USA; Hamad Medical Corporation, Doha, Qatar.

Margaret A Pisani (MA)

Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Stephen R Baldassarri (SR)

Section of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

Amy Justice (A)

Veterans Affairs Connecticut Healthcare System, West Haven, CT, USA; Departments of Internal Medicine and Health Policy and Management, Yale University Schools of Medicine and Public Health, New Haven, CT, USA.

Emily C Williams (EC)

Department of Health Services, University of Washington School of Public Health, Seattle, WA, USA; Center of Innovation for Veteran-Centered and Value-Driven Care, VA Puget Sound Health Services Research & Development, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiviraux › Antirétroviraux › Agents antiVIH › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Maladies cardiovasculaires › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Maladies du système immunitaire › Déficits immunitaires › Infections à VIH › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Personnes › Survivants › Survivants à long terme d'une infection à VIH › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études longitudinales › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Établissements, main d'oeuvre et services de soins de santé › Services de santé › Services de médecine préventive › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de protection › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Appréciation des risques › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Facteurs de risque › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Comportement › Comportement de réduction des risques › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Personnes › Fumeurs › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Comportement › Fumer › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Comportement › Comportement en matière de santé › Arrêter de fumer › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents de sevrage tabagique › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Phénomènes physiques › Temps › Facteurs temps › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Qualité des soins de santé › Mécanismes d'évaluation des soins de santé › Évaluation des résultats et des processus en soins de santé › Évaluation de résultat (soins) › Résultat thérapeutique › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Régions géographiques › Amériques › Amérique du Nord › États-Unis › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Caractéristiques de la population › Santé › Santé des anciens combattants › Receipt and predictors of smoking cessation...
questionsmedicales.fr › Phénomènes microbiologiques › Phénomènes physiologiques viraux › Charge virale › Receipt and predictors of smoking cessation...